• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

diagnostics

Image of a neon sign with the word no lit up next to an unlit yes
Biotech

FDA rejects another ultrarare disease prospect

The biotech’s investigational product is designed to treat an extraordinarily rare genetic metabolic disorder that impacts fewer than 1,000 Americans.
Gabrielle Masson Sep 8, 2025 10:59am
Cue Health COVID

UPDATE: Cue Health shuts down operations, lays off staff

May 22, 2024 2:15pm
Butterfly Network South Africa Ultrasound training

Butterfly Network expands Africa maternal ultrasound efforts

Apr 15, 2024 10:58am
Food and Drug Administration

The road ahead as FDA tries to tame lab-developed tests

Oct 10, 2023 10:00am
concept of chess board with letters MA

CRO Cirion acquired by French diagnostic group Cerba HealthCare

Sep 14, 2023 5:30am
Pink Porcelain Anatomical Heart - stock photo Paul CampbellGetty Images

Bayer, Huma build online prediction tool for heart disease

Feb 6, 2023 9:53am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings